Minerva Neurosciences | NERV - PE Price to Earnings

Stock Price
6.37
Daily Change
0.33 5.46%
Monthly
2.25%
Yearly
244.32%
Q1 Forecast
7.31

Minerva Neurosciences reported 14.32 in PE Price to Earnings for its fiscal quarter ending in March of 2021.





Pe Change Date
Acadia Pharmaceuticals 11.61 2.09 Dec/2025
Adma Biologics 29.73 12.48 Dec/2025
ALKERMES 19.54 4.64 Dec/2025
AstraZeneca 27.29 5.8 Dec/2025
BioCryst Pharmaceuticals 6.06 1.07K Dec/2025
Bristol-Myers Squibb 9.28 1.04 Dec/2025
Cipla 27.74 3.55 Dec/2025
Clal Biotechnology 11.67 2.62 Dec/2022
Compugen 4.06 75.75 Dec/2025
CSL 16.16 9.59 Dec/2025
Eli Lilly 40.21 9.66 Dec/2025
Esperion Therapeutics 129.79 129 Dec/2024
GlaxoSmithKline 11.15 0.29 Dec/2025
Grifols 11.2 1.08 Dec/2025
Halozyme Therapeutics 23.16 7.7 Dec/2025
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
J&J 23.62 0.86 Dec/2025
Merck 13.92 5.08 Dec/2025
Neurocrine Biosciences 835.47 802.2 Dec/2025
Novartis 17.85 2.11 Dec/2025
Novavax 2.01 1.07 Dec/2025
Pfizer 14.48 5.18 Dec/2025
Roche Holding 16.09 3.51 Dec/2025
Sanofi 11.99 1.58 Dec/2025
Takeda 235.05 184.95 Dec/2025
Vanda Pharmaceuticals 16.79 7.07 Jun/2023